Effect of food and relative bioavailability following single doses of diclofenac 150mg hydrogel bead (HGB) capsules in healthy humans
✍ Scribed by K. M. Thakker; S. Mangat; W. Wagner; J. Castellana; G. M. Kochak
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 428 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The effect of food on the bioavailabilty of diclofenac from a 150mg diclofenac hydrogel bead (HGB) capsule was evaluated in 12 healthy male subjects in a fed and fasted state. Additionally, the fasting bioavailability of diclofenac from a 150mg diclofenac HGB capsule relative to diclofenac sodium in buffered aqueous solution was evaluated in these same 12 subjects. The study was designed as an open‐label, randomized, single‐dose, 3×3 Latin‐square crossover trial balanced for residual effects. A 2‐week washout period was maintained between treatments. Blood samples were collected at frequent intervals over a 24‐h period with plasma being separated and analyzed for diclofenac using a validated HPLC method.
The administration of the 150mg diclofenac HGB capsule dose within 30 min following a standardized breakfast minimally affected the bioavailability of diclofenac relative to administration under fasted conditions (7 per cent decrease in AUC~(0‐24)~, p>0·05). There was, however, a 38 per cent decrease (p<0·05) in the C~max~ and a three‐fold increase (p<0·05) in T~max~ for the fed HGB capsule administration.
Under fasted conditions, significant differences in mean pharmacokinetic parameters were found between the 150mg diclofenac HGB capsule and diclofenac sodium in buffered aqueous solution. The extent of availability of diclofenac from the HGB capsule was only 59 per cent relative to that from the solution (p<0·05). There was a 92 per cent decrease in the maximum plasma diclofenac concentration (C~max~, p<0·05) and an eight‐fold increase (p<0·05) in the median time required to reach this maximum level (T~max~) following HGB capsule administration.
In conclusion, post‐prandial administration of the 150mg diclofenac HGB capsule resulted in a minimal decrease in bioavailability. The oral bioavailability of the diclofenac sodium in 150 mg diclofenac HGB capsules is significantly decreased relative to that of diclofenac sodium in solution.